Exact Mass: 441.2012

platencimycin

C24H27NO7 (441.1787)

D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D000890 - Anti-Infective Agents

Imidapril hydrochloride

C20H28ClN3O6 (441.1667)

D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

troglitazone

C24H27NO5S (441.161)

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5234; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5241; ORIGINAL_PRECURSOR_SCAN_NO 5238 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5206; ORIGINAL_PRECURSOR_SCAN_NO 5205 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5244; ORIGINAL_PRECURSOR_SCAN_NO 5241 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5240; ORIGINAL_PRECURSOR_SCAN_NO 5238 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5233; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9800; ORIGINAL_PRECURSOR_SCAN_NO 9795 CONFIDENCE standard compound; INTERNAL_ID 701; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9806; ORIGINAL_PRECURSOR_SCAN_NO 9803 Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine?PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.

Mandelonitrile rutinoside

C20H27NO10 (441.1635)

Mandelonitrile rutinoside is found in fruits. Mandelonitrile rutinoside is a constituent of the fruit of purple passion fruit (Passiflora edulis). Constituent of the fruit of purple passion fruit (Passiflora edulis). Mandelonitrile rutinoside is found in fruits.

18-Carboxy-dinor-LTE4

C21H31NO7S (441.1821)

18-carboxy-dinor-LTE4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 18-carboxy-dinor-LTE4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)

Vilazodone

C26H27N5O2 (441.2165)

Vilazodone is a novel compound with combined high affinity and selectivity for the 5-hydroxytryptamine (5-HT) transporter and 5-HT(1A) receptors. It has been shown to be equally efficacious as other antidepressants with similar gastrointestinal side effects and possibly with reduced sexual side effects and weight gain. Vilazodone is an antidepressant agent that can used as an alternative for patients who cannot tolerate therapy with other antidepressant classes such as selective serotonin reuptake inhibitors or serotonin norepinephrine reuptake inhibitors. Treatment should be titrated towards the target dose, which is 40mg per day. D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active?serotonin?reuptake inhibitor (SSRI) and partial?5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders[1][2].

3-N-(2-Fluoroethyl)spiperone

C25H29F2N3O2 (441.2228)

D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D019275 - Radiopharmaceuticals

Bacmecillinam

C20H31N3O6S (441.1933)

6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]-

C25H23N5O3 (441.1801)

Brivanib alaninate

C22H24FN5O4 (441.1812)

Cerivastatin lactone

C26H32FNO4 (441.2315)

Db-cAMP

C18H28N5O6P (441.1777)

Deflazacort

C25H31NO6 (441.2151)

4-(2-((4-(2-(Pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinolin-7-yl)oxy)ethyl)morpholine

C26H27N5O2 (441.2165)

troglitazone

C24H27NO5S (441.161)

A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BG - Thiazolidinediones C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98241 - Thiazolidinedione Antidiabetic Agent C274 - Antineoplastic Agent > C2122 - Cell Differentiating Agent > C1934 - Differentiation Inducer D007004 - Hypoglycemic Agents Troglitazone is an orally active PPARγ agonist, with EC50s of 550 nM and 780 nM for human and murine?PPARγ receptor, respectively. Troglitazone has anticancer activity, prevents and inhibits the development of type 2 diabetes.

4-Hydroxy-5-[[4-[[(2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]methoxy]phenyl]methyl]-3H-1,3-thiazol-2-one

C24H27NO5S (441.161)

Ergomet

C19H23N3O2.C4H4O4 (441.19)

Ergometrine maleate is a maleate salt resulting form the reaction of equimolar amounts of maleic acid and ergometrine. It is used in the active management of the third stage of labour, and to prevent or treat postpartum of postabortal haemorrhage caused by uterine atony: by maintaining uterine contraction and tone, blood vessels in the uterine wall are compressed and blood flow reduced. It has a role as an oxytocic and a diagnostic agent. It contains an ergometrine. An ergot alkaloid (ERGOT ALKALOIDS) with uterine and VASCULAR SMOOTH MUSCLE contractile properties. C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D012102 - Reproductive Control Agents > D010120 - Oxytocics

(-)-Apicularen A

C25H31NO6 (441.2151)

SCHEMBL5691455

C24H31N3O5 (441.2264)

Fleephilone

C24H27NO7 (441.1787)

A organic heterotetracyclic compound isolated from the fermentation broth of Trichoderma harzianum and exhibits anti-HIV activity.

N-Acetoacetyl-N-deacetylcolchicine

C24H27NO7 (441.1787)

Daphmanidin F

C25H31NO6 (441.2151)

Phorbasin D

C22H35NO6S (441.2185)

2-O-(2-Amino-3-methylbutanoyl)sucrose

C17H31NO12 (441.1846)

CCG-50207

C25H23N5OS (441.1623)

Azocyclotin

C20H39N3Sn (441.2166)

14(S)-hydroxyplatencin|14S-hydroxyplatencin|platencin A3

C24H27NO7 (441.1787)

Parsonsianine

C21H31NO9 (441.1999)

13-hydroxy platencin|platencin A1

C24H27NO7 (441.1787)

12-hydroxyplatencin|platencin A2

C24H27NO7 (441.1787)

Floridanine

C21H31NO9 (441.1999)

A pyrrolizine alkaloid that is onetine in which the hydroxy hydrogen has been replaced by an acetyl group. Origin: Plant; SubCategory_DNP: Alkaloids derived from ornithine, Pyrrolizidine alkaloids

O,O-diacetylepiglaufidine

C24H27NO7 (441.1787)

3-O-(2-butenoyl)-11-O-(3-hydroxybutanoyl)hamayne

C24H27NO7 (441.1787)

(3S,6S)-8-methyl-6-[(phenylcarbonyl)oxy]-8-azabicyclo[3.2.1]oct-3-yl 4-hydroxy-3,5-dimethoxybenzoate|6beta-benzoyloxy-3alpha-(4-hydroxy-3,5-dimethoxybenzoyloxy)tropane

C24H27NO7 (441.1787)

C22H32ClNO6

C22H32ClNO6 (441.1918)

GPPAT

C19H31N5O7 (441.2223)

beta-D-fructofuranosyl-(2->1)-alpha-D-[2-O-L-valyl]glucopyranoside

C17H31NO12 (441.1846)

Et glycoside,N-Ac,4,6-dibenzoyl-alpha-D-Pyranose-2-Amino-2,3-dideoxy-ribo-hexopyranose

C24H27NO7 (441.1787)

4-[(beta-D-glucopyranosyl)-(1->3)-(alpha-L-rhamnopyranosyl)]phenylacetonitrile

C20H27NO10 (441.1635)

C24H27NO7

C24H27NO7 (441.1787)

Tunichrome Mm-2|Tunichrome Mm2

C23H27N3O6 (441.19)

C18H27N5O6S

C18H27N5O6S (441.1682)

Phe Tyr Ile

C24H31N3O5 (441.2264)

Ile Tyr Phe

C24H31N3O5 (441.2264)

Tyr Ile Phe

C24H31N3O5 (441.2264)

Ile Phe Tyr

C24H31N3O5 (441.2264)

Phe Glu Phe

C23H27N3O6 (441.19)

Tyr Phe Ile

C24H31N3O5 (441.2264)

Ser His Ala Lys

C18H31N7O6 (441.2336)

Glu Phe Phe

C23H27N3O6 (441.19)

Phe Ile Tyr

C24H31N3O5 (441.2264)

Pro Tyr Tyr

C23H27N3O6 (441.19)

Phe Phe Glu

C23H27N3O6 (441.19)

Tyr Pro Tyr

C23H27N3O6 (441.19)

BISOPROLOL

C22H35NO8 (441.2363)

Deflazacort (Calcort)

C25H31NO6 (441.2151)

Ala His Lys Ser

C18H31N7O6 (441.2336)

Ala His Asn Thr

C17H27N7O7 (441.1972)

Ala His Gln Ser

C17H27N7O7 (441.1972)

Ala His Ser Lys

C18H31N7O6 (441.2336)

Ala His Ser Gln

C17H27N7O7 (441.1972)

Ala His Thr Asn

C17H27N7O7 (441.1972)

Ala Lys His Ser

C18H31N7O6 (441.2336)

Ala Lys Ser His

C18H31N7O6 (441.2336)

Ala Asn His Thr

C17H27N7O7 (441.1972)

Mebeverine metabolite (1-Butanol, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]- glucuronide)

C22H35NO8 (441.2363)

Ala Asn Thr His

C17H27N7O7 (441.1972)

Ala Gln His Ser

C17H27N7O7 (441.1972)

Ala Gln Ser His

C17H27N7O7 (441.1972)

Ala Ser His Lys

C18H31N7O6 (441.2336)

Ala Ser His Gln

C17H27N7O7 (441.1972)

Ala Ser Lys His

C18H31N7O6 (441.2336)

Ala Ser Gln His

C17H27N7O7 (441.1972)

Ala Thr His Asn

C17H27N7O7 (441.1972)

Ala Thr Asn His

C17H27N7O7 (441.1972)

Asp Gly His Asn

C16H23N7O8 (441.1608)

Asp Gly Asn His

C16H23N7O8 (441.1608)

Asp His Gly Asn

C16H23N7O8 (441.1608)

Asp His Asn Gly

C16H23N7O8 (441.1608)

Asp Asn Gly His

C16H23N7O8 (441.1608)

Asp Asn His Gly

C16H23N7O8 (441.1608)

Asp Asn Pro Pro

C18H27N5O8 (441.186)

Asp Pro Asn Pro

C18H27N5O8 (441.186)

Asp Pro Pro Asn

C18H27N5O8 (441.186)

Gly Asp His Asn

C16H23N7O8 (441.1608)

Gly Asp Asn His

C16H23N7O8 (441.1608)

Gly His Asp Asn

C16H23N7O8 (441.1608)

Gly His Lys Thr

C18H31N7O6 (441.2336)

Gly His Asn Asp

C16H23N7O8 (441.1608)

Gly His Gln Thr

C17H27N7O7 (441.1972)

Gly His Thr Lys

C18H31N7O6 (441.2336)

Gly His Thr Gln

C17H27N7O7 (441.1972)

Gly Lys His Thr

C18H31N7O6 (441.2336)

Gly Lys Thr His

C18H31N7O6 (441.2336)

Gly Asn Asp His

C16H23N7O8 (441.1608)

Gly Asn His Asp

C16H23N7O8 (441.1608)

Gly Gln His Thr

C17H27N7O7 (441.1972)

Gly Gln Thr His

C17H27N7O7 (441.1972)

Gly Thr His Lys

C18H31N7O6 (441.2336)

Gly Thr His Gln

C17H27N7O7 (441.1972)

Gly Thr Lys His

C18H31N7O6 (441.2336)

Gly Thr Gln His

C17H27N7O7 (441.1972)

His Ala Lys Ser

C18H31N7O6 (441.2336)

His Ala Asn Thr

C17H27N7O7 (441.1972)

His Ala Gln Ser

C17H27N7O7 (441.1972)

His Ala Ser Lys

C18H31N7O6 (441.2336)

His Ala Ser Gln

C17H27N7O7 (441.1972)

His Ala Thr Asn

C17H27N7O7 (441.1972)

His Asp Gly Asn

C16H23N7O8 (441.1608)

His Asp Asn Gly

C16H23N7O8 (441.1608)

His Gly Asp Asn

C16H23N7O8 (441.1608)

His Gly Lys Thr

C18H31N7O6 (441.2336)

His Gly Asn Asp

C16H23N7O8 (441.1608)

His Gly Gln Thr

C17H27N7O7 (441.1972)

His Gly Thr Lys

C18H31N7O6 (441.2336)

His Gly Thr Gln

C17H27N7O7 (441.1972)

His Lys Ala Ser

C18H31N7O6 (441.2336)

His Lys Gly Thr

C18H31N7O6 (441.2336)

His Lys Ser Ala

C18H31N7O6 (441.2336)

His Lys Thr Gly

C18H31N7O6 (441.2336)

His Asn Ala Thr

C17H27N7O7 (441.1972)

His Asn Asp Gly

C16H23N7O8 (441.1608)

His Asn Gly Asp

C16H23N7O8 (441.1608)

His Asn Thr Ala

C17H27N7O7 (441.1972)

His Gln Ala Ser

C17H27N7O7 (441.1972)

His Gln Gly Thr

C17H27N7O7 (441.1972)

His Gln Ser Ala

C17H27N7O7 (441.1972)

His Gln Thr Gly

C17H27N7O7 (441.1972)

His Ser Ala Lys

C18H31N7O6 (441.2336)

His Ser Ala Gln

C17H27N7O7 (441.1972)

His Ser Lys Ala

C18H31N7O6 (441.2336)

His Ser Gln Ala

C17H27N7O7 (441.1972)

His Thr Ala Asn

C17H27N7O7 (441.1972)

His Thr Gly Lys

C18H31N7O6 (441.2336)

His Thr Gly Gln

C17H27N7O7 (441.1972)

His Thr Lys Gly

C18H31N7O6 (441.2336)

His Thr Asn Ala

C17H27N7O7 (441.1972)

His Thr Gln Gly

C17H27N7O7 (441.1972)

10-Hydroxydesmethylnortriptyline glucuronide

C24H27NO7 (441.1787)

Tyr Phe Leu

C24H31N3O5 (441.2264)

Leu Tyr Phe

C24H31N3O5 (441.2264)

Lys Ala His Ser

C18H31N7O6 (441.2336)

Lys Ala Ser His

C18H31N7O6 (441.2336)

Oxprenolol glucuronide

C21H31NO9 (441.1999)

Lys Gly His Thr

C18H31N7O6 (441.2336)

Lys Gly Thr His

C18H31N7O6 (441.2336)

Lys His Ala Ser

C18H31N7O6 (441.2336)

Lys His Gly Thr

C18H31N7O6 (441.2336)

Lys His Ser Ala

C18H31N7O6 (441.2336)

Lys His Thr Gly

C18H31N7O6 (441.2336)

Lys Ser Ala His

C18H31N7O6 (441.2336)

Lys Ser His Ala

C18H31N7O6 (441.2336)

Lys Thr Gly His

C18H31N7O6 (441.2336)

Lys Thr His Gly

C18H31N7O6 (441.2336)

Leu Phe Tyr

C24H31N3O5 (441.2264)

Phe Leu Tyr

C24H31N3O5 (441.2264)

Asn Ala His Thr

C17H27N7O7 (441.1972)

Asn Ala Thr His

C17H27N7O7 (441.1972)

Asn Asp Gly His

C16H23N7O8 (441.1608)

Asn Asp His Gly

C16H23N7O8 (441.1608)

Asn Asp Pro Pro

C18H27N5O8 (441.186)

Asn Gly Asp His

C16H23N7O8 (441.1608)

Asn Gly His Asp

C16H23N7O8 (441.1608)

Asn His Ala Thr

C17H27N7O7 (441.1972)

Asn His Asp Gly

C16H23N7O8 (441.1608)

Asn His Gly Asp

C16H23N7O8 (441.1608)

Asn His Thr Ala

C17H27N7O7 (441.1972)

Asn Pro Asp Pro

C18H27N5O8 (441.186)

Asn Pro Pro Asp

C18H27N5O8 (441.186)

Asn Thr Ala His

C17H27N7O7 (441.1972)

Asn Thr His Ala

C17H27N7O7 (441.1972)

Pro Asp Asn Pro

C18H27N5O8 (441.186)

Pro Asp Pro Asn

C18H27N5O8 (441.186)

Pro Asn Asp Pro

C18H27N5O8 (441.186)

Pro Asn Pro Asp

C18H27N5O8 (441.186)

Pro Pro Asp Asn

C18H27N5O8 (441.186)

Pro Pro Asn Asp

C18H27N5O8 (441.186)

Pro Pro Gln Thr

C19H31N5O7 (441.2223)

Pro Pro Thr Gln

C19H31N5O7 (441.2223)

Pro Gln Pro Thr

C19H31N5O7 (441.2223)

Pro Gln Thr Pro

C19H31N5O7 (441.2223)

Pro Thr Pro Gln

C19H31N5O7 (441.2223)

Pro Thr Gln Pro

C19H31N5O7 (441.2223)

Gln Ala His Ser

C17H27N7O7 (441.1972)

Gln Ala Ser His

C17H27N7O7 (441.1972)

Gln Gly His Thr

C17H27N7O7 (441.1972)

Gln Gly Thr His

C17H27N7O7 (441.1972)

Gln His Ala Ser

C17H27N7O7 (441.1972)

Gln His Gly Thr

C17H27N7O7 (441.1972)

Gln His Ser Ala

C17H27N7O7 (441.1972)

Gln His Thr Gly

C17H27N7O7 (441.1972)

Tyr Leu Phe

C24H31N3O5 (441.2264)

Gln Pro Pro Thr

C19H31N5O7 (441.2223)

Gln Pro Thr Pro

C19H31N5O7 (441.2223)

Gln Ser Ala His

C17H27N7O7 (441.1972)

Gln Ser His Ala

C17H27N7O7 (441.1972)

Gln Thr Gly His

C17H27N7O7 (441.1972)

Gln Thr His Gly

C17H27N7O7 (441.1972)

Gln Thr Pro Pro

C19H31N5O7 (441.2223)

Ser Ala His Lys

C18H31N7O6 (441.2336)

Ser Ala His Gln

C17H27N7O7 (441.1972)

Ser Ala Lys His

C18H31N7O6 (441.2336)

Ser Ala Gln His

C17H27N7O7 (441.1972)

Ser His Ala Gln

C17H27N7O7 (441.1972)

Ser His Lys Ala

C18H31N7O6 (441.2336)

Ser His Gln Ala

C17H27N7O7 (441.1972)

Ser Lys Ala His

C18H31N7O6 (441.2336)

Ser Lys His Ala

C18H31N7O6 (441.2336)

Ser Gln Ala His

C17H27N7O7 (441.1972)

Ser Gln His Ala

C17H27N7O7 (441.1972)

Tyr Tyr Pro

C23H27N3O6 (441.19)

Phe Tyr Leu

C24H31N3O5 (441.2264)

Thr Ala His Asn

C17H27N7O7 (441.1972)

Thr Ala Asn His

C17H27N7O7 (441.1972)

Thr Gly His Lys

C18H31N7O6 (441.2336)

Thr Gly His Gln

C17H27N7O7 (441.1972)

Thr Gly Lys His

C18H31N7O6 (441.2336)

Thr Gly Gln His

C17H27N7O7 (441.1972)

Thr His Ala Asn

C17H27N7O7 (441.1972)

Thr His Gly Lys

C18H31N7O6 (441.2336)

Thr His Gly Gln

C17H27N7O7 (441.1972)

Thr His Lys Gly

C18H31N7O6 (441.2336)

Thr His Asn Ala

C17H27N7O7 (441.1972)

Thr His Gln Gly

C17H27N7O7 (441.1972)

Thr Lys Gly His

C18H31N7O6 (441.2336)

Thr Lys His Gly

C18H31N7O6 (441.2336)

Thr Asn Ala His

C17H27N7O7 (441.1972)

Thr Asn His Ala

C17H27N7O7 (441.1972)

Thr Pro Pro Gln

C19H31N5O7 (441.2223)

Thr Pro Gln Pro

C19H31N5O7 (441.2223)

Thr Gln Gly His

C17H27N7O7 (441.1972)

Thr Gln His Gly

C17H27N7O7 (441.1972)

Thr Gln Pro Pro

C19H31N5O7 (441.2223)

PS(12:0/0:0)

C18H36NO9P (441.2128)

Vilazodone

C26H27N5O2 (441.2165)

D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017367 - Selective Serotonin Reuptake Inhibitors D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D017366 - Serotonin Receptor Agonists D018377 - Neurotransmitter Agents > D014179 - Neurotransmitter Uptake Inhibitors C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants D049990 - Membrane Transport Modulators Vilazodone (EMD 68843; SB 659746A) is a potent, selective and orally active?serotonin?reuptake inhibitor (SSRI) and partial?5-HT1A receptor agonist. Vilazodone exhibits antidepressant efficacy in vivo can be used for the research of major depressive disorder (MDD) and affective disorders[1][2].

Mandelonitrile rutinoside

C20H27NO10 (441.1635)

18-carboxy-19,20-dinor-leukotriene E4

C21H31NO7S (441.1821)

An icosanoid that is leukotriene E4 in which two methylene groups are removed from the carboxyalkyl chain attached to the non-conjugated double bond.

LPS 12:0

C18H36NO9P (441.2128)

N,N-ethylenebis[N-(carboxymethyl)glycine], compound with 2,2,2-nitrilotri(ethanol)

C16H31N3O11 (441.1958)

Clothixamide

C24H28ClN3OS (441.1642)

N-Me-phe-obzl p-tosylate

C24H27NO5S (441.161)

3H-Indolium, 2-2-(4,5-dihydro-3,5-diphenyl-1H-pyrazol-1-yl)ethenyl-1,3,3-trimethyl-, chloride

C28H28ClN3 (441.1972)

4-(dibiphenyl-4-ylaMino)phenylboronic acid

C30H24BNO2 (441.19)

Nifekalant Hydrochloride

C19H28ClN5O5 (441.1779)

D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents

Brivanib alaninate

C22H24FN5O4 (441.1812)

C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

bacmecillinam

C20H31N3O6S (441.1933)

Perbufylline

C23H28FN5O3 (441.2176)

Fmoc-D-Arg(NO2)-OH

C21H23N5O6 (441.1648)

Fmoc-Ser(tbdms)-OH

C24H31NO5Si (441.1971)

(+)-Norpropoxyphene (maleate)

C25H31NO6 (441.2151)

LY2109761

C26H27N5O2 (441.2165)

3-Phenyl-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine

C24H27NO5S (441.161)

cis-clomiphene hcl

C26H29Cl2NO (441.1626)

6-[2-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-di(propan-2-yl)pyridin-3-yl]ethenyl]-4-hydroxyoxan-2-one

C26H32FNO4 (441.2315)

Quetiapine Fumarate

C23H27N3O4S (441.1722)

Quetiapine hemifumarate is a 5-HT receptors agonist with a pEC50 of 4.77 for human 5-HT1A receptor. Quetiapine hemifumarate is a dopamine receptor antagonist with a pIC50 of 6.33 for human D2 receptor. Quetiapine hemifumarate has moderate to high affinity for the human D2, HT1A, 5-HT2A, 5-HT2C receptor with pKis of 7.25, 5.74, 7.54, 5.55. Antidepressant and anxiolytic effects[1].

Deflazacort

C25H31NO6 (441.2151)

H - Systemic hormonal preparations, excl. sex hormones and insulins > H02 - Corticosteroids for systemic use > H02A - Corticosteroids for systemic use, plain > H02AB - Glucocorticoids C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000893 - Anti-Inflammatory Agents

Trequinsin hydrochloride

C24H28ClN3O3 (441.1819)

Tomeglovir

C23H27N3O4S (441.1722)

amberlite(r) irc-50

C23H37Cl2N3O (441.2314)

1,3-Pyrrolidinedicarboxylic acid, 4-(1,3-benzodioxol-5-yl)-2-(4-Methoxyphenyl)-, 1-(1,1-diMethylethyl) ester, (2α,3β,4α)-

C24H27NO7 (441.1787)

2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,2-[bis(2-hydroxyethyl)amino]ethanol

C16H31N3O11 (441.1958)

Fmoc-Arg(NO2 )-OH

C21H23N5O6 (441.1648)

(5r)-5-(4-{[(2r)-6-Hydroxy-2,5,7,8-Tetramethyl-3,4-Dihydro-2h-Chromen-2-Yl]methoxy}benzyl)-1,3-Thiazolidine-2,4-Dione

C24H27NO5S (441.161)

N-(1-Carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine

C23H27N3O6 (441.19)

Crisnatol mesylate

C24H27NO5S (441.161)

C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent

6H-Dipyrido[3,2-b:2,3-e][1,4]diazepin-6-one, 11-ethyl-5,11-dihydro-5-methyl-8-[2-[(1-oxido-4-quinolinyl)oxy]ethyl]-

C25H23N5O3 (441.1801)

Platencin A1

C24H27NO7 (441.1787)

A polycyclic cage that is the 9-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.

2-[[2-(2-Cyanophenoxy)-1-oxoethyl]amino]-5,5,7,7-tetramethyl-4,6-dihydrothieno[2,3-c]pyridine-3-carboxylic acid ethyl ester

C23H27N3O4S (441.1722)

2,4-dihydroxy-3-({3-[(2S,3S,4aR,8S,8aR)-3-hydroxy-8-methyl-10-methylidene-7-oxo-1,3,4,7,8,8a-hexahydro-2H-2,4a-ethanonaphthalen-8-yl]propanoyl}amino)benzoic acid

C24H27NO7 (441.1787)

Pro-Tyr-Tyr

C23H27N3O6 (441.19)

Bisoprolol monofumarate

C22H35NO8 (441.2363)

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents

(2r,4s)-2-[(r)-Benzylcarbamoyl-phenylacetyl-methyl]-5,5-dimethyl-thiazolidine-4-carboxylic acid

C23H27N3O4S (441.1722)

Ergonovine maleate

C23H27N3O6 (441.19)

C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist D012102 - Reproductive Control Agents > D010120 - Oxytocics

18-Carboxy-dinor-LTE4

C21H31NO7S (441.1821)

4-Hydroxy-5-[[4-[[(2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl]methoxy]phenyl]methyl]-3H-1,3-thiazol-2-one

C24H27NO5S (441.161)

[(2S,3R,4R,6R)-3-hydroxy-2-methyl-6-(12-oxo-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4,6,8,10,15,17,19,21-nonaen-3-yl)oxan-4-yl]azanium

C26H25N4O3+ (441.1927)

Thioplatencin

C24H27NO5S (441.161)

6-[2-[4-(4-Fluorophenyl)-2,6-diisopropyl-5-(methoxymethyl)-3-pyridyl]vinyl]-4-hydroxy-tetrahydropyran-2-one

C26H32FNO4 (441.2315)

platencin A3

C24H27NO7 (441.1787)

A polycyclic cage that is the 4-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.

(3S)-3-(1,3-benzodioxol-5-yl)-1-(3,5-dimethyl-1-piperidinyl)-3-(2-hydroxy-4,6-dimethoxyphenyl)-1-propanone

C25H31NO6 (441.2151)

(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-(4-hydroxyphenyl)propanoic acid

C23H27N3O6 (441.19)

Glu-Phe-Phe

C23H27N3O6 (441.19)

2-[3-[3-[3-(1-Imidazolyl)propyl]-4-oxo-2-quinazolinyl]propyl]isoindole-1,3-dione

C25H23N5O3 (441.1801)

N-(3-methylphenyl)-4-[4-(4-morpholinyl)-3-nitrophenyl]-1-phthalazinamine

C25H23N5O3 (441.1801)

5,7-Dimethyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylic acid [2-[2-(3,4-diethoxyphenyl)ethylamino]-2-oxoethyl] ester

C22H27N5O5 (441.2012)

N-tert-butyl-2-[[5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(phenylmethyl)acetamide

C23H27N3O4S (441.1722)

3-[[2-[[(2-Methylpropan-2-yl)oxy-oxomethyl]amino]-1-oxoethyl]hydrazo]-3-oxo-2-phenylpropanoic acid (phenylmethyl) ester

C23H27N3O6 (441.19)

Phe-Glu-Phe

C23H27N3O6 (441.19)

Tyr-Leu-Phe

C24H31N3O5 (441.2264)

3-(phenylazo)-N-acetyl-L-tyrosylglycylglycine

C21H23N5O6 (441.1648)

Ac-D-Phe-His-D-Pro

C22H27N5O5 (441.2012)

(1R,4S,6R,7R,11Z)-4-hydroxy-4-[(1R)-1-hydroxyethyl]-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H31NO9 (441.1999)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxyacetyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b][1]benzofuran-3-yl]-N-(pyridin-3-ylmethyl)acetamide

C23H27N3O6 (441.19)

(2S,3S,3aR,9bR)-1-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one

C24H28ClN3O3 (441.1819)

(2S,3R)-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C25H32FN3O3 (441.2428)

(2R,3S)-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C25H32FN3O3 (441.2428)

(2R,3R)-2-[[(2-fluorophenyl)methyl-methylamino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-[(E)-prop-1-enyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C25H32FN3O3 (441.2428)

N-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(5R,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C23H31N5O4 (441.2376)

N-[(5R,6S,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C23H31N5O4 (441.2376)

N-[(5S,6R,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(5S,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2R,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

1-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

1-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

1-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

(1R,2aR,8bR)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C24H28ClN3O3 (441.1819)

(2R,3R,3aS,9bS)-1-[(2-chlorophenyl)methyl]-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one

C24H28ClN3O3 (441.1819)

N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-5-methylsulfonyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-5-propyl-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(5R,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C23H31N5O4 (441.2376)

N-[(5S,6S,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C23H31N5O4 (441.2376)

N-[(5S,6R,9R)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C23H31N5O4 (441.2376)

N-[(5S,6R,9S)-5-methoxy-3,6,8,9-tetramethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-2-pyrazinecarboxamide

C23H31N5O4 (441.2376)

N-[(5R,6S,9S)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-8-methylsulfonyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]acetamide

C20H31N3O6S (441.1933)

N-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-8-propyl-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]methanesulfonamide

C21H35N3O5S (441.2297)

N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-(4-methyl-1-piperazinyl)-2-oxoethyl]-3-oxanyl]-2-methoxybenzenesulfonamide

C20H31N3O6S (441.1933)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

N-(1,3-benzodioxol-5-ylmethyl)-2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[1-oxo-2-(3-pyridinyl)ethyl]amino]-2-oxanyl]acetamide

C23H27N3O6 (441.19)

2-[(2R,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5S,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2R,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2R,5S,6S)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1R)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

2-[(2S,5R,6R)-6-(hydroxymethyl)-5-[[(2-methoxyanilino)-oxomethyl]amino]-2-oxanyl]-N-[(1S)-1-phenylethyl]acetamide

C24H31N3O5 (441.2264)

1-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

1-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

1-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

1-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(1-piperidinyl)ethyl]-3,6-dihydro-2H-pyran-3-yl]-3-[4-(trifluoromethyl)phenyl]urea

C21H26F3N3O4 (441.1875)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(3-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(2-methoxyethylamino)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide

C23H27N3O6 (441.19)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(2-pyridinylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(2-methoxy-1-oxoethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(pyridin-4-ylmethyl)acetamide

C23H27N3O6 (441.19)

(1S,2aS,8bS)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C24H28ClN3O3 (441.1819)

(1S,2aR,8bR)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C24H28ClN3O3 (441.1819)

(1R,2aS,8bS)-N-(3-chlorophenyl)-1-(hydroxymethyl)-2-(4-oxanylmethyl)-1,2a,3,8b-tetrahydroazeto[2,3-c]quinoline-4-carboxamide

C24H28ClN3O3 (441.1819)

[(1R)-1-[(2,5-difluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H29F2N3O2 (441.2228)

[(1S)-1-[(2,5-difluorophenyl)methyl]-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanol

C25H29F2N3O2 (441.2228)

[(1S)-7-methoxy-9-methyl-1-(3-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H27N3O4S (441.1722)

[(1R)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H27N3O4S (441.1722)

[(1S)-7-methoxy-9-methyl-1-(4-methylphenyl)sulfonyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol

C23H27N3O4S (441.1722)

Phe-Leu-Tyr

C24H31N3O5 (441.2264)

Ile-Phe-Tyr

C24H31N3O5 (441.2264)

Leu-Phe-Tyr

C24H31N3O5 (441.2264)

Leu-Tyr-Phe

C24H31N3O5 (441.2264)

Tyr-Ile-Phe

C24H31N3O5 (441.2264)

Tyr-Tyr-Pro

C23H27N3O6 (441.19)

Phe-Ile-Tyr

C24H31N3O5 (441.2264)

Phe-Phe-Glu

C23H27N3O6 (441.19)

Tyr-Phe-Leu

C24H31N3O5 (441.2264)

Ile-Tyr-Phe

C24H31N3O5 (441.2264)

Phe-Tyr-Ile

C24H31N3O5 (441.2264)

Phe-Tyr-Leu

C24H31N3O5 (441.2264)

Tyr-Phe-Ile

C24H31N3O5 (441.2264)

(1R,9S,10S,11S)-12-[(3-chlorophenyl)methyl]-N-ethyl-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C24H28ClN3O3 (441.1819)

(2R,3R,3aS,9bS)-1-[(2-chlorophenyl)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H28ClN3O3 (441.1819)

(1S,9R,10R,11R)-12-[(3-chlorophenyl)methyl]-N-ethyl-10-(hydroxymethyl)-6-oxo-5-[(E)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide

C24H28ClN3O3 (441.1819)

(2S,3S,3aR,9bR)-1-[(2-chlorophenyl)methyl]-N-ethyl-3-(hydroxymethyl)-6-oxo-7-[(Z)-prop-1-enyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide

C24H28ClN3O3 (441.1819)

5-aminopentyl 6-O-alpha-D-glucopyranuronosyl-alpha-D-glucopyranoside

C17H31NO12 (441.1846)

Lnaps 4:0/N-7:0

C17H32NO10P (441.1764)

Lnaps 8:0/N-3:0

C17H32NO10P (441.1764)

Lnaps 7:0/N-4:0

C17H32NO10P (441.1764)

Lnaps 9:0/N-2:0

C17H32NO10P (441.1764)

Lnaps 3:0/N-8:0

C17H32NO10P (441.1764)

Lnaps 2:0/N-9:0

C17H32NO10P (441.1764)

Lnaps 5:0/N-6:0

C17H32NO10P (441.1764)

Lnaps 6:0/N-5:0

C17H32NO10P (441.1764)

2-Amino-3-[(3-dodecanoyloxy-2-hydroxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C18H36NO9P (441.2128)

2-Amino-3-[(3-butanoyloxy-2-heptanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C17H32NO10P (441.1764)

2-Amino-3-[hydroxy-(2-octanoyloxy-3-propanoyloxypropoxy)phosphoryl]oxypropanoic acid

C17H32NO10P (441.1764)

2-Amino-3-[(2-hexanoyloxy-3-pentanoyloxypropoxy)-hydroxyphosphoryl]oxypropanoic acid

C17H32NO10P (441.1764)

3-[(3-Acetyloxy-2-nonanoyloxypropoxy)-hydroxyphosphoryl]oxy-2-aminopropanoic acid

C17H32NO10P (441.1764)

Platensimycin

C24H27NO7 (441.1787)

A monocarboxylic acid amide obtained by the formal condensation of the amino group of 3-amino-2,4-dihydroxybenzoic acid with the carboxy group of the oxatetracyclic cage component. It is an antibiotic isolated from Streptomyces platensis and exhibits inhibitory activity against fatty acid synthase. D000963 - Antimetabolites > D000960 - Hypolipidemic Agents > D054872 - Fatty Acid Synthesis Inhibitors D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites D000890 - Anti-Infective Agents

1-dodecanoyl-glycero-3-phosphoserine

C18H36NO9P (441.2128)

platencin A2

C24H27NO7 (441.1787)

A polycyclic cage that is the 3-hydroxy derivative of platencin. It is isolated from Streptomyces platensis.

LPE 12:2;O3

C17H32NO10P (441.1764)

LPS 12:0/0:0

C18H36NO9P (441.2128)

PS 2:0_9:0

C17H32NO10P (441.1764)

Tyr-Pro-Tyr

C23H27N3O6 (441.19)

ST 19:2;O7;Gly

C21H31NO9 (441.1999)

ST 20:1;O6;Gly

C22H35NO8 (441.2363)

ST 23:6;O4;Gly

C25H31NO6 (441.2151)

ST 19:3;O4;Tau

C21H31NO7S (441.1821)

ST 20:2;O3;Tau

C22H35NO6S (441.2185)

T0467

C24H26F3N5 (441.214)

T0467 activates parkin mitochondrial translocation in a PINK1-dependent manner in vitro. T0467 do not induce mitochondrial accumulation of PINK1in dopaminergic neurons. T0467 is a potential compound for PINK1-Parkin signaling activation, and can be used for parkinson's disease and related disorders research[1].

3-oxo-n-[(10s)-3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl]butanimidic acid

C24H27NO7 (441.1787)

(2r,3r,4s,5s,6r)-2-{[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl (2s)-2-amino-3-methylbutanoate

C17H31NO12 (441.1846)

2,4-dihydroxy-3-({1-hydroxy-3-[(5s,9s)-9-hydroxy-5-methyl-12-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO7 (441.1787)

2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,6r,8s,9s)-9-hydroxy-5-methyl-12-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO7 (441.1787)

2,4-dihydroxy-3-[(1-hydroxy-3-{11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl}propylidene)amino]benzoic acid

C24H27NO7 (441.1787)

6-[(1r,2s)-1-hydroxy-2-{[(2s,3s,4s,5r,6r)-6-(hydroxymethyl)-3,4,5-trimethoxyoxan-2-yl]oxy}propyl]-2-imino-1h-pteridin-4-ol

C18H27N5O8 (441.186)

12-(acetyloxy)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-yl acetate

C24H27NO7 (441.1787)

(1s,13s,15r,18r)-15-{[(3s)-3-hydroxybutanoyl]oxy}-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-yl but-2-enoate

C24H27NO7 (441.1787)

(1r,4r,6r,7r,11z)-4-hydroxy-4-[(1s)-1-hydroxyethyl]-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H31NO9 (441.1999)

methyl (1r,5s,6r,9r,10s,13r,19r,21r)-9-[(acetyloxy)methyl]-21-hydroxy-5-methyl-20-oxa-3-azaheptacyclo[11.5.2.1⁶,¹⁰.0¹,⁹.0²,⁶.0¹³,¹⁹.0¹⁶,¹⁹]henicosa-2,16-diene-17-carboxylate

C25H31NO6 (441.2151)

(11r,15r,17r)-5-[(4r,5s,6r)-4-(dimethylamino)-5-hydroxy-6-methyloxan-2-yl]-17-methyl-12,16-dioxatetracyclo[8.7.0.0³,⁸.0¹¹,¹⁵]heptadeca-1(10),3,5,7-tetraene-2,9,13-trione

C24H27NO7 (441.1787)

2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO7 (441.1787)

12-hydroxy-5-methyl-4,6-dioxo-15-(penta-1,3-dien-1-yl)-14-oxa-9-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,7-trien-5-yl 3-hydroxybutanoate

C24H27NO7 (441.1787)

4-hydroxy-4-(1-hydroxyethyl)-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H31NO9 (441.1999)

3-({3-[(1s,5s,9s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-1-hydroxypropylidene}amino)-2,4-dihydroxybenzoic acid

C24H27NO7 (441.1787)

3-oxo-n-{3,4,5,14-tetramethoxy-13-oxotricyclo[9.5.0.0²,⁷]hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl}butanimidic acid

C24H27NO7 (441.1787)

6-(1-hydroxy-2-{[6-(hydroxymethyl)-3,4,5-trimethoxyoxan-2-yl]oxy}propyl)-2-imino-1h-pteridin-4-ol

C18H27N5O8 (441.186)

n-(3-{7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.0³,⁸]heptadeca-3,5,7-trien-11-yl}prop-1-en-1-yl)hepta-2,4-dienimidic acid

C25H31NO6 (441.2151)

3-[(3-{5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl}-1-hydroxypropylidene)amino]-2,4-dihydroxybenzoic acid

C24H27NO7 (441.1787)

2-amino-6-hydroxy-7-methyl-5-[(2s)-2-[(1r,3r,4s,5s,8s,9s)-4,8,9-trimethyl-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-3-yl]propanoyl]naphthalene-1,4-dione

C24H27NO7 (441.1787)

(1s,2s,12s,15r)-1,15-dihydroxy-2,7-dimethoxy-12-(2-methylprop-1-en-1-yl)-10,13,19-triazapentacyclo[11.7.0.0³,¹¹.0⁴,⁹.0¹⁵,¹⁹]icosa-3(11),4,6,8-tetraene-14,20-dione

C23H27N3O6 (441.19)

2-(4-{[(2r,3r,4s,5r,6r)-3,5-dihydroxy-6-methyl-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}phenyl)acetonitrile

C20H27NO10 (441.1635)

(2s)-2-{[(2s)-2-{[(2s,3r)-3-amino-1,2-dihydroxy-4-phenylbutylidene]amino}-1-hydroxy-3-methylbutylidene]amino}-3-phenylpropanoic acid

C24H31N3O5 (441.2264)

2,4-dihydroxy-3-[(1-hydroxy-3-{9-hydroxy-5-methyl-12-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl}propylidene)amino]benzoic acid

C24H27NO7 (441.1787)

(1r,6r,7r)-4-hydroxy-4-(1-hydroxyethyl)-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H31NO9 (441.1999)

2-{[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 2-amino-3-methylbutanoate

C17H31NO12 (441.1846)

(2e,10e)-n-[(2r,3s,4as,8r,8ar)-8-chloro-2,4a-dihydroxy-8a-methyl-5-oxo-2,3,4,8-tetrahydro-1-benzopyran-3-yl]-12-hydroxydodeca-2,10-dienimidic acid

C22H32ClNO6 (441.1918)

9-ethyl-4,5,9-trihydroxy-4-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

C21H31NO9 (441.1999)

(12s,13r)-12-hydroxy-5-methyl-4,6-dioxo-15-[(1e,3e)-penta-1,3-dien-1-yl]-14-oxa-9-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,7-trien-5-yl 3-hydroxybutanoate

C24H27NO7 (441.1787)

n-[2,6-dihydroxy-3-(sulfanylcarbonyl)phenyl]-3-[(1s,5s,6r,8s)-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propanimidic acid

C24H27NO5S (441.161)

2,4-dihydroxy-3-[(1-hydroxy-3-{10-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl}propylidene)amino]benzoic acid

C24H27NO7 (441.1787)

(9s,12r)-12-(acetyloxy)-3,4,15-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-16-yl acetate

C24H27NO7 (441.1787)

(2e,6e)-8-(4,6-dihydroxy-2-{[5-(hydroxymethyl)furan-2-yl]methyl}-1-oxo-3h-isoindol-5-yl)-2,6-dimethylocta-2,6-dienoic acid

C24H27NO7 (441.1787)

2,4-dihydroxy-3-({1-hydroxy-3-[(1r,5s,6s,8r,11r)-11-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO7 (441.1787)

3-({3-[(1s,5s,6r,7s,9s,10s)-5,9-dimethyl-4-oxo-8-oxatetracyclo[7.2.1.1⁷,¹⁰.0¹,⁶]tridec-2-en-5-yl]-1-hydroxypropylidene}amino)-2,4-dihydroxybenzoic acid

C24H27NO7 (441.1787)

(2e)-n-[(2r,4e)-2-(3,4-dimethoxyphenyl)-3-oxo-5-phenylpent-4-en-1-yl]-3-phenylprop-2-enimidic acid

C28H27NO4 (441.194)

n-[(2r,3s,4as,8r,8ar)-8-chloro-2,4a-dihydroxy-8a-methyl-5-oxo-2,3,4,8-tetrahydro-1-benzopyran-3-yl]-12-hydroxydodeca-2,10-dienimidic acid

C22H32ClNO6 (441.1918)

2-({2-[(3-amino-1,2-dihydroxy-4-phenylbutylidene)amino]-1-hydroxy-3-methylbutylidene}amino)-3-phenylpropanoic acid

C24H31N3O5 (441.2264)

(1r,21s,22s,23r)-22-hydroxy-11,23-dimethyl-21-propyl-24-oxa-20-azahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁸,¹³]pentacosa-2,4,7(16),8,10,12,14,18-octaene-6,17-dione

C28H27NO4 (441.194)

2-{4-[(3,5-dihydroxy-6-methyl-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]phenyl}acetonitrile

C20H27NO10 (441.1635)

(1r,4r,5r,8r,9s,19r)-9-ethyl-4,5,9-trihydroxy-4-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

C21H31NO9 (441.1999)

(21s,22s,23r)-22-hydroxy-11,23-dimethyl-21-propyl-24-oxa-20-azahexacyclo[19.3.1.0²,¹⁹.0⁵,¹⁸.0⁷,¹⁶.0⁸,¹³]pentacosa-2,4,7(16),8,10,12,14,18-octaene-6,17-dione

C28H27NO4 (441.194)

(1s,13s,15r,18r)-15-{[(3s)-3-hydroxybutanoyl]oxy}-5,7-dioxa-12-azapentacyclo[10.5.2.0¹,¹³.0²,¹⁰.0⁴,⁸]nonadeca-2,4(8),9,16-tetraen-18-yl (2e)-but-2-enoate

C24H27NO7 (441.1787)

2,4-dihydroxy-3-({1-hydroxy-3-[(1s,5s,6r,8s,10s)-10-hydroxy-5-methyl-9-methylidene-4-oxotricyclo[6.2.2.0¹,⁶]dodec-2-en-5-yl]propylidene}amino)benzoic acid

C24H27NO7 (441.1787)

(e,2z,4z)-n-[(1e)-3-{7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.0³,⁸]heptadeca-3,5,7-trien-11-yl}prop-1-en-1-yl]hepta-2,4-dienimidic acid

C25H31NO6 (441.2151)

2-amino-6-hydroxy-7-methyl-5-(2-{4,8,9-trimethyl-7-oxo-2,6-dioxabicyclo[3.3.1]nonan-3-yl}propanoyl)naphthalene-1,4-dione

C24H27NO7 (441.1787)

(5r,12s,13r,16r)-12-hydroxy-5-methyl-4,6-dioxo-15-[(1e,3e)-penta-1,3-dien-1-yl]-14-oxa-9-azatetracyclo[7.6.1.0²,⁷.0¹³,¹⁶]hexadeca-1(15),2,7-trien-5-yl (3s)-3-hydroxybutanoate

C24H27NO7 (441.1787)

(2s)-2-phenyl-2-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}acetonitrile

C20H27NO10 (441.1635)

(e,2z,4z)-n-[(1e)-3-[(1s,11s,13r,15r)-7,15-dihydroxy-9-oxo-10,17-dioxatricyclo[11.3.1.0³,⁸]heptadeca-3,5,7-trien-11-yl]prop-1-en-1-yl]hepta-2,4-dienimidic acid

C25H31NO6 (441.2151)

2-amino-6-hydroxy-5-[(2e,4r)-4-[(2s,3r,4r,5s)-4-hydroxy-3,5-dimethyl-6-oxooxan-2-yl]-2-methylpent-2-enoyl]-7-methylnaphthalene-1,4-dione

C24H27NO7 (441.1787)

(4s,6r,7r,11z)-4-hydroxy-4-[(1s)-1-hydroxyethyl]-6,7,14-trimethyl-3,8,17-trioxo-2,9-dioxa-14-azabicyclo[9.5.1]heptadec-11-en-7-yl acetate

C21H31NO9 (441.1999)

(4r,7r)-n-[(2s)-1-hydroxypropan-2-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0²,⁷.0¹²,¹⁶]hexadeca-1(16),2,9,12,14-pentaene-4-carboximidic acid; maleic acid

C23H27N3O6 (441.19)

(1r,4r,5s,8r,9s,19r)-9-ethyl-4,5,9-trihydroxy-4-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione

C21H31NO9 (441.1999)